• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER OCCLUDER (UNKNOWN); TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER OCCLUDER (UNKNOWN); TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Device Problem Inadequacy of Device Shape and/or Size (1583)
Patient Problem Mitral Regurgitation (1964)
Event Type  Injury  
Manufacturer Narrative
As reported in a research article, an amplatzer device was explanted four years after implant due to the mitral valve leaflet hitting the edge of the device, causing mitral regurgitation.The results of the investigation are inconclusive since the device was not returned for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Event Description
It was reported through a research article identifying a 32mm amplatzer occluder that may be related to explant two years post implant.The 32mm amplatzer device was successfully implanted.Two years post implant, the patient developed an apical systolic murmur grade 2/6.No shunt was detected and the device appeared in place, however, in the early systolic phase, the base of the anterior mitral leaflet seemed to collide with the inferior edge of the device.By four years post-implant, mitral regurgitation (mr) had increased to severe and it was decided to perform surgical intervention.Surgical inspection revealed the presence of diffuse prolapsed anterior mitral leaflet.Repair was accomplished through direct suture concomitant with removal of the amplatzer device and atrial septum closure with a competitor's gore-tex cardiovascular patch.Specific patient information is documented as unknown.Details are listed in the attached article, titled "images of mitral valve perforation due to atrial septal occluder device".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER OCCLUDER (UNKNOWN)
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer Contact
pamela yip
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key9649687
MDR Text Key178353454
Report Number2135147-2020-00018
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Reporter Country CodeKS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Reporter Occupation Physician
Type of Report Initial
Report Date 01/30/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 01/09/2020
Initial Date FDA Received01/30/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age22 YR
-
-